Crocin inhibits KBTBD7 to prevent excessive inflammation and cardiac dysfunction following myocardial infarction

Chunju Yuan1, Zhongpu Chen1, Qianxing Zhou1

  • 1Department of Cardiovascular Medicine, Zhongda Hospital Southeast University, Nanjing, Jiangsu 210009, P.R. China.

Insights

Crocin demonstrates a protective effect against myocardial infarction (MI) by reducing inflammation and cell apoptosis. This mechanism involves the inhibition of kelch repeat and BTB domain-containing protein 7 (KBTBD7), thereby modulating key inflammatory signaling pathways.

Area of Science:

  • Cardiovascular Biology
  • Pharmacology
  • Molecular Medicine

Background:

  • Myocardial infarction (MI) is a critical condition resulting from coronary artery disease.
  • Crocin, derived from Gardenia jasminoides and Crocus sativus, exhibits known cardioprotective properties.
  • Kelch repeat and BTB domain-containing protein 7 (KBTBD7) is a newly identified protein within the BTB-kelch family.

Purpose of the Study:

  • To investigate the cardioprotective effects of crocin against myocardial ischemia-reperfusion injury (MIRI) in a rat model.
  • To elucidate the interaction between crocin and KBTBD7.
  • To explore the role of KBTBD7 in inflammatory responses and signaling pathways relevant to MIRI.

Main Methods:

  • A rat model of myocardial ischemia-reperfusion injury (MIRI) was established by ligating the left anterior descending coronary artery.
  • Crocin was administered at doses of 100 mg/kg and 200 mg/kg to assess its effects on myocardial tissue.
  • Inflammatory cytokine levels (IL-1β, IL-6, TNFα), myocardial cell apoptosis (TUNEL assay), KBTBD7 expression (Western blotting), and signaling pathways (MAPK, NF-κB) were analyzed.

Main Results:

  • Crocin treatment significantly reduced levels of inflammatory cytokines (IL-1β, IL-6, TNFα) and myocardial cell apoptosis in MIRI rats.
  • Crocin inhibited the release of inflammatory cytokines induced by rmHMGB1 and rmHSP60 in RAW264.7 cells.
  • KBTBD7 was identified as a direct target of crocin; KBTBD7 knockdown suppressed inflammatory cytokine production and inhibited p38 and NF-κB signaling pathways.

Conclusions:

  • Crocin exhibits significant protective effects against myocardial ischemia-reperfusion injury in rats.
  • The cardioprotective mechanism of crocin involves the inhibition of KBTBD7, leading to reduced inflammatory responses and myocardial cell apoptosis.
  • Targeting KBTBD7 presents a potential therapeutic strategy for managing myocardial infarction.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
482
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
139
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
210
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
232
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
672